Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim
Berberine attenuates diabetic kidney injury via FOXO1/SP1-associated regulation of renal SGLT-2 expression. (PubMed, Chin Med) - Oct 1, 2026 - "BBR attenuates diabetic kidney injury, at least in part, through FOXO1/SP1-associated regulation of renal SGLT-2 expression. These findings support the involvement of a FOXO1/SP1-associated regulatory axis in renal tubular glucose handling under diabetic conditions." 
Journal • Diabetes • Diabetic Nephropathy • Renal Disease • FOXO1
http://www.ncbi.nlm.nih.gov/pubmed/42811360
 
Changnian Li; Fengyi Zhang; Hui Cheng; Jingjing Pan; Shuai Zhao; Wenbo Wang; Xin Wang; Xinhe Wang; Xinyuan Han; Yahui Li; Yaxin Chen; Yu Zhang; Yujie Li; Ziyang Cheng
 
Oct 1, 2026
 
Prev Next